22 January 2016
Company Announcements Office Australian Securities Exchange 10th Floor
20 Bond Street
SYDNEY NSW 2000
Dear Sir
ResApp Health Limited (ASX: RAP) ("Company") advises that it has issued 18,093,750 Shares on the conversion of 18,093,750 unlisted options (exercisable at $0.026, expiring 31 December 2016) ("Options") with funds totalling
$470,437.50 having been received. 375,000 Shares issued will remain escrowed until 2 June 2016.
The Company confirms it has released a cleansing prospectus ("Prospectus") pursuant to Section 708A(11) of the Corporations Act. The purpose of the Prospectus is to remove any trading restrictions in relation to the Shares issued pursuant to the exercise of the Options.
Yours faithfully
ResApp Health Limited ABN 51 094 468 318
Level 24, 44 St Georges Tce, Perth WA 6000
T +61 8 6211 5099 E info@resapphealth.com.au W www.resapphealth.com.auResApp Health Limited issued this content on 2016-01-22 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 2016-01-22 09:09:02 UTC
Original Document: http://www.resapphealth.com.au/wp-content/uploads/2016/01/1518117.pdf